People in Places

• Doros Platika, MD, will become chairman of Cohera Medical (Pittsburgh), on Dec. 1. Platika is currently president/CEO of the Pittsburgh Life Sciences Greenhouse and chairman and CEO and co-founder of the Supercentenarian Research Foundation. Previously, he worked for MPM Capital (Boston), a venture capital firm focused on the life sciences, and Centagenetix. Cohera Medical is focused on biodegradable surgical adhesives.

• Robert Krieger has been named CEO of Delray Medical Center and Pinecrest Rehabilitation Hospital (both West Palm Beach, Florida). Krieger has more than 20 years experience as a healthcare executive. Most recently, he was with HCA and served as CEO of Orange Park Medical Center.

• Bruce Boggs was appointed senior vice president, global marketing and external affairs, for IMS Health (Fairfield, Connecticut). Previously, Boggs was senior vice president and president, IMS Americas. He joined IMS in 2002 as senior vice president of U.S. Sales and subsequently took on marketing in the region. Before joining IMS, he served in a variety of sales, marketing, strategic development and general management positions during a 26-year career with IBM. IMS also reported that William Nelligan has been appointed president, IMS Americas, responsible for IMS operations in the U.S., Canada and Latin America. IMS Health provides market intelligence to the pharmaceutical and healthcare industries.

• Medical Capital Advisors (MCA; Waltham, Massachusetts) a merchant bank that provides advisory services to the medical technology sector, said that it has added two physicians and a device industry executive to its medical technology investment banking team: David Barash, MD; Haya Maymon, MD; and Jeff Rovell, PhD. Barash, who was named senior medical director, practices emergency medicine. He has served as executive vice president and medical director for Access Cardiosystems, and as CEO of Esotech Innovations, a start-up firm delivering a platform technology for esophageal-based critical care monitoring and therapy. Maymon joined the firm as medical director. Maymon is a practicing internist and assistant professor at Tufts University School of Medicine. Rovell has joined MCA’s advisory board. Rovell first became involved in the industry in 1973 when he was appointed assistant director of R&D at Howmedica. Rovell also worked for Johnson & Johnson as a clinical research associate in the OB/GYN product line.